Patent Expiry
ABUS: VEMLIDY: recorded patent 8754065 expiry
August 15, 2032 · TENOFOVIR ALAFENAMIDE FUMARATE. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- August 15, 2032
- Company
- Arbutus Biopharma Corp (ABUS)
- Drug
- TENOFOVIR ALAFENAMIDE FUMARATE
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
VEMLIDY: recorded patent 8754065 expiry
Orange Book application NDA208464, product 001, listed patent 8754065 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source